Showing 7571-7580 of 18620 results for "".
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
https://reachmd.com/programs/acc-action-center/no-effect-on-the-primary-endpoint-with-Ssglt2i-post-mi-but-significant-effect-on-hf-hospitalizations/24287/ACC.24 - Javed Butler shares the findings of the EMPACT-MI trial, in which empagliflozin had no effect on the primary endpoint in patients with acute MI but significant effect on HF hospitalizations.Visible Benefit of Compression for Leukocytoclastic Vasculitis
https://reachmd.com/programs/practical-dermatology/visible-benefit-of-compression-for-leukocytoclastic-vasculitis/24212/The use of compression stockings has been suggested in the management of leukocytoclastic vasculitis (LCV), however there are a lack of studies in the literature that provide evidence of the benefit of compression therapy in the treatment of LCV.1,2 Here we present a case that visually demonstratesProstate Cancer Research: Why Disparities Exist in Mortality and Trial Access
https://reachmd.com/programs/project-oncology/prostate-cancer-research-why-disparities-exist-in-mortality-and-trial-access/17881/Find out why there are disparities in mortality as well as access and participation in clinical trials among vulnerable prostate cancer populations.COVID-19 Vaccines & Abnormal Mammograms: A Proposed Plan of Care
https://reachmd.com/programs/covid-19-frontlines/covid-19-vaccines-abnormal-mammograms-a-proposed-plan-of-care/12579/While COVID-19 vaccines are a key victory in the battle against the pandemic, they’re having an unexpected side effect: abnormal mammograms.Combination Therapy Slows Myopia Progression in Children with Premyopia
https://reachmd.com/programs/eye-on-ocular-health/combination-therapy-slows-myopia-progression-in-children-with-premyopia/36447/New Recommendations for Colorectal Cancer Screening
https://reachmd.com/programs/the-jama-report/new-recommendations-colorectal-cancer-screening/8185/The U.S. Preventative Services Task Force has updated the recommendations regarding colorectal cancer screening.Early Axial Length Changes Signal Red Light Therapy Success in Myopia Control
https://reachmd.com/programs/eye-on-ocular-health/early-axial-length-changes-signal-red-light-therapy-success-in-myopia-control/36281/The Crohn’s & Colitis Foundation's Camp Oasis: A Clinician's Perspective
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/the-crohns-colitis-foundations-camp-oasis-a-clinicians-perspective/10083/Dr. Philip Stein talks with clinicians Dr. Neilanjan Nandi and Susan Peck about their experiences at CCF's Camp Oasis.Updates in Undifferentiated Eczema: Taking a Practical Approach to Care
https://reachmd.com/programs/clinicians-roundtable/updates-in-undifferentiated-eczema-taking-a-practical-approach-to-care/32390/Here’s a quick summary of a session on undifferentiated eczema that was presented at the Maui Derm 2025 conference.Bridging Gaps with Blood-Based CRC Screening
https://reachmd.com/programs/on-the-frontlines-of-colorectal-cancer/bridging-gaps-blood-crc-screening/49172/Blood-based testing has the potential to expand access to colorectal cancer (CRC) screening for average-risk adults who decline colonoscopy or stool-based options. In this discussion with Ryan Quigley, Dr. Aasma Shaukat unpacks recent findings on test performance, clinical use cases, and possible re